In this work, we found that the anti-allergic effects of SP seem to occur through the blocked phosphorylation of ERK1/2, JNK, and p38 MAPK signaling pathways, and suppress COX-2 and iNOS expression in DNCB-induced AD skin lesions (Figure 4 and Figure 5). The gene discussed is PTGS2; the disease is Alzheimer disease.